Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genaxxon bioscience is a private German life science tools and molecular biology reagent company focused on supplying products and custom solutions for research, diagnostics, and industrial laboratory use. Its portfolio centers on PCR, RT-PCR, qPCR, nucleic acid research reagents, peptides, recombinant proteins, antibodies, biochemicals, and selected cell biology products. The company also offers customized products such as bespoke cell culture media, peptide synthesis, and special packaging quantities, and it markets molecular diagnostic kits including Legionella testing products. Genaxxon bioscience appears to operate primarily as a commercial supplier and manufacturer rather than a therapeutic drug developer, with production activities in Germany and an ISO 9001:2015-certified quality system. The business is best understood as a life science tools, assay reagent, and laboratory consumables provider serving academic, diagnostic, and industrial customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genaxxon bioscience.